The Effect of a Developed Perioperative Rehabilitation Pathway Following Lumbar Arthrodesis
1 other identifier
interventional
80
1 country
1
Brief Summary
To compare the current rehabilitation pathway with the implementation of a newly developed rehabilitation pathway for patients with a single and double level lumbar arthrodesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2018
CompletedFirst Submitted
Initial submission to the registry
January 26, 2018
CompletedFirst Posted
Study publicly available on registry
February 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 3, 2024
December 1, 2023
7 years
January 26, 2018
December 28, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Oswestry Disability Index (ODI)
questionnaire measuring disability related to low back pain
Postoperative: 1 week
Oswestry Disability Index (ODI)
questionnaire measuring disability related to low back pain
Postoperative: 6 weeks
Oswestry Disability Index (ODI)
questionnaire measuring disability related to low back pain
Postoperative: 3 months
Oswestry Disability Index (ODI)
questionnaire measuring disability related to low back pain
Postoperative: 6 months
Oswestry Disability Index (ODI)
questionnaire measuring disability related to low back pain
Postoperative: 1 year
Secondary Outcomes (8)
Numeric Rating scale (NRS)
Postoperative: 1 week, 6 weeks, 3 months, 6 months, 1 year
Tampa scale for Kinesiophobia (TSK)
Postoperative: 1 week, 6 weeks, 3 months, 6 months, 1 year
Pain Catastrophizing scale (PCS)
Postoperative: 1 week, 6 weeks, 3 months, 6 months, 1 year
Depression Anxiety stress scale (DASS)
Postoperative: 1 week, 6 weeks, 3 months, 6 months, 1 year
EuroQol five dimensions questionnaire (EQ-5D)
Postoperative: 1 week, 6 weeks, 3 months, 6 months, 1 year
- +3 more secondary outcomes
Study Arms (2)
Control group
ACTIVE COMPARATORusual care
Intervention group
EXPERIMENTALRehabilitation with a biopsychosocial focus
Interventions
Rehabilitation with a biopsychosocial focus
Eligibility Criteria
You may qualify if:
- Lumbar single and double level arthrodesis
- Signed informed consent
- Posterior Lumbar interbody fusion (PLIF), Posterolateral lumbar fusion (PLF) and Transforaminal lumbar interbody fusion (TLIF)
You may not qualify if:
- Previous arthrodesis in the lumbar spine
- Musculoskeletal disorders which interfere with functional outcome, f.e. severe lower limb problems not related to the lumbar surgery
- Presence of one of the following pathologies:Parkinson Multiple sclerose (MS), Cerebral vascular accident (CVA), Peripheral neuropathies, Circulatory disorders, Gout, Rheumatoid disorders, Neoplasia, Septic arthritis, Pregnancy, Vestibular disorder, Infectious diseases
- Accident at work or lawsuit
- Low cognition
- Not able to speak Dutch
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitaire Ziekenhuizen KU Leuvenlead
- KU Leuvencollaborator
- UHasseltcollaborator
Study Sites (1)
UZ/KU Leuven
Leuven, Vlaams Brabant, 3000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bart Depreitere, PhD, MD
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Thijs Swinnen, MSc, PT
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Tinne Thys, MSc, PT
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Wim Dankaerts, PhD, PT
KU Leuven
- PRINCIPAL INVESTIGATOR
Simon Brumagne, PhD, PT
KU Leuven
- PRINCIPAL INVESTIGATOR
Peter Van Wambeke, MD
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Lieven Moke, PhD, MD
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Sebastiaan Schelfaut, MD
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Ann Spriet, MSc, PT
Universitaire Ziekenhuizen KU Leuven
- PRINCIPAL INVESTIGATOR
Lotte Janssens, PhD, PT
Hasselt University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2018
First Posted
February 9, 2018
Study Start
January 3, 2018
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
January 3, 2024
Record last verified: 2023-12